Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abbott Laboratories (ABT) vs eBay Inc (EBAY) Price & Performance

Abbott Laboratories
eBay Inc

Price performance

Price movement over the last 24 hours

Key statistics

Abbott Laboratories vs eBay Inc — how do they compare? Abbott Laboratories trades at $95.18 (market cap $166.94B), while eBay Inc trades at $114.24 (market cap $50.94B). The key difference: Abbott Laboratories is far larger — about 3.3× eBay Inc's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.

ABTEBAY
Market Cap
$166.94B$50.94B
Sector
HealthConsumer Cyclical
52-Week High
$136.62$118.96
52-Week Low
$82.57$75.33
Enterprise Value
$193.69B$54.28B
Dividend Yield
2.63%1.08%
Volume
5,186,418

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abbott Laboratories

Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.

The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.

eBay Inc

EBAY trades at $114.71, down slightly by 0.11% today. The stock shows strong profitability with a 17.61% net income margin and has beaten earnings estimates for three consecutive quarters. Technical indicators are bullish, with the price above key moving averages. Recent news highlights GameStop's unsolicited takeover interest, adding speculative momentum. Cash flow turned negative in 2025 but is projected to recover in 2026.

The outlook is mixed: solid fundamentals and earnings beats support upside, but the stock trades above the analyst consensus target of $109.50. Risks include takeover uncertainty and competitive pressures. Wall Street sentiment is neutral with a slight buy bias, though valuation multiples like P/E of 26.25 suggest limited near-term growth potential.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Read more on ABT

About eBay Inc

eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.

Read more on EBAY